650 related articles for article (PubMed ID: 25741886)
1. Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment.
Kaplan RI; De Moraes CG; Cioffi GA; Al-Aswad LA; Blumberg DM
JAMA Ophthalmol; 2015 May; 133(5):560-7. PubMed ID: 25741886
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.
Choi JA; Song LD; Choi S; Park SM; Kwon JW; Jee D
Medicine (Baltimore); 2019 Jan; 98(2):e14026. PubMed ID: 30633194
[TBL] [Abstract][Full Text] [Related]
3. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.
King AJ; Fernie G; Azuara-Blanco A; Burr JM; Garway-Heath T; Sparrow JM; Vale L; Hudson J; MacLennan G; McDonald A; Barton K; Norrie J
Br J Ophthalmol; 2018 Jul; 102(7):922-928. PubMed ID: 29074496
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
7. The Primary Tube Versus Trabeculectomy Study: Methodology of a Multicenter Randomized Clinical Trial Comparing Tube Shunt Surgery and Trabeculectomy with Mitomycin C.
Gedde SJ; Chen PP; Heuer DK; Singh K; Wright MM; Feuer WJ; Schiffman JC; Shi W;
Ophthalmology; 2018 May; 125(5):774-781. PubMed ID: 29248173
[TBL] [Abstract][Full Text] [Related]
8. Comparative Cost-effectiveness of Trabeculectomy versus MicroShunt in the US Medicare System.
Atik A; Fahy ET; Rhodes LA; Samuels BC; Mennemeyer ST; Girkin CA
Ophthalmology; 2022 Oct; 129(10):1142-1151. PubMed ID: 35636620
[TBL] [Abstract][Full Text] [Related]
9. Cost-Utility Analysis of Glaucoma Medication Adherence.
Newman-Casey PA; Salman M; Lee PP; Gatwood JD
Ophthalmology; 2020 May; 127(5):589-598. PubMed ID: 31767436
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of glaucoma reoperations in the Tube Versus Trabeculectomy (TVT) Study.
Saheb H; Gedde SJ; Schiffman JC; Feuer WJ;
Am J Ophthalmol; 2014 Jun; 157(6):1179-1189.e2. PubMed ID: 24531027
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Primary Treatment for People with Advanced Glaucoma: Five-Year Results of the Treatment of Advanced Glaucoma Study.
King AJ; Hudson J; Azuara-Blanco A; Burr J; Kernohan A; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; Davidson T; Vale L; MacLennan G;
Ophthalmology; 2024 Jul; 131(7):759-770. PubMed ID: 38199528
[TBL] [Abstract][Full Text] [Related]
12. A Canadian Cost-Utility Analysis of 2 Trabecular Microbypass Stents at Time of Cataract Surgery in Patients with Mild to Moderate Open-Angle Glaucoma.
Ahmed IIK; Podbielski DW; Patel V; Falvey H; Murray J; Botteman M; Goeree R
Ophthalmol Glaucoma; 2020; 3(2):103-113. PubMed ID: 32672593
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China.
Li R; Zhang K; Lu Z; Mou D; Wang J; Li H; Fan S; Wang N; Liu H
BMJ Open; 2023 Sep; 13(9):e073219. PubMed ID: 37673456
[TBL] [Abstract][Full Text] [Related]
14. Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity.
Guedes RAP; Guedes VMP; Gomes CEM; Chaoubah A
Medicine (Baltimore); 2016 Dec; 95(52):e5745. PubMed ID: 28033286
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of treating normal tension glaucoma.
Li EY; Tham CC; Chi SC; Lam DS
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3394-9. PubMed ID: 23599342
[TBL] [Abstract][Full Text] [Related]
16. Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.
Takihara Y; Inatani M; Ogata-Iwao M; Kawai M; Inoue T; Iwao K; Tanihara H
JAMA Ophthalmol; 2014 Jan; 132(1):69-76. PubMed ID: 24232829
[TBL] [Abstract][Full Text] [Related]
17. Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis.
Leinonen S; Kotaniemi K; Kivelä T; Majander A
JAMA Ophthalmol; 2015 Nov; 133(11):1323-8. PubMed ID: 26402863
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada.
Patel V; Ahmed I; Podbielski D; Falvey H; Murray J; Goeree R
J Med Econ; 2019 Apr; 22(4):390-401. PubMed ID: 30663456
[TBL] [Abstract][Full Text] [Related]
19. Three-year follow-up of the tube versus trabeculectomy study.
Gedde SJ; Schiffman JC; Feuer WJ; Herndon LW; Brandt JD; Budenz DL;
Am J Ophthalmol; 2009 Nov; 148(5):670-84. PubMed ID: 19674729
[TBL] [Abstract][Full Text] [Related]
20. Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up.
Gedde SJ; Feuer WJ; Lim KS; Barton K; Goyal S; Ahmed IIK; Brandt JD;
Ophthalmology; 2020 Mar; 127(3):333-345. PubMed ID: 31727428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
